BUSINESS COMBINATIONS, ACQUISITION PAYABLE AND DISCONTINUED OPERATIONS (Details Narrative) - USD ($)				6 Months Ended
	May 19, 2022	Nov. 05, 2019	Oct. 15, 2018	Jun. 30, 2023	Nov. 01, 2023	Feb. 28, 2023	Jan. 31, 2023	Dec. 29, 2018
Restructuring Cost and Reserve [Line Items]
Cash consideration, paid					$ 157,000
EZCLonE Manufacturing [Member]
Restructuring Cost and Reserve [Line Items]
Ownership interest								100.00%
Purchase and Sale Agreement [Member]
Restructuring Cost and Reserve [Line Items]
Agreement descriptions		the Company amended the Agreement with one 24.5% shareholder of EZ-CLONE to extend the date to purchase the remaining 49% of stock of EZ-CLONE in exchange for a 20% extension fee (a total of $171,000 for the 49% or $85,500 for each 24.5% shareholder) of the $855,000 cash payable at the earlier of the closing of $2,000,000 in funding or nine months (July 2020). The Company did not close the purchase of the remaining 49% of stock of EZ-CLONE by the extended deadline.
Bridgetown Mushrooms LLC [Member]
Restructuring Cost and Reserve [Line Items]
Forgiveness of the indebtedness	$ 43,000
Promissory note	$ 138,546
Installments paid				$ 50,000		$ 50,000	$ 38,546
Restricted shares of the common stock	5,923,345
Secured debt				161,546
EZCLonE Enterprises inc [Member]
Restructuring Cost and Reserve [Line Items]
Total purchase price			$ 4,000,000
Cash purchase price			1,500,000
Stock issued for purchase price			$ 2,500,000
Agreement descriptions			At closing, we paid 51% of this amount totaling $2,040,000 via a (i) a cash payment of $645,000; and (ii) the issuance of 715,385 restricted shares of our common stock valued $1,395,000. The Agreement called for the Company, upon delivery of the remaining 49% of EZ-Clone stock, to acquire such stock within one year for $1,960,000, payable as follows: (i) a cash payment of $855,000; and (ii) the issuance of Company’s common stock at a value of $1,105,000.
Gain on deconsolidation				1,700,000
Derecognition of acquisition				$ 2,100,000